Michael D. Gershon, M.D.
[更多]
An Economical Design and Processing of Lipophilic Drugs for Fast-Releasing Water Dispersible Formulations Princeton Docket # 18-3396-1 The Prud’homme group has developed a novel, economical, and scalable formulation and process to prepare nanoparticles from poorly water soluble drugs in order to imp.....
[更多]
Researchers at UCLA have developed antibodies to the following mouse nuclear proteins:Polyclonals: Helios; HP-1 alpha; HP-1 beta; HP-1 gamma; Mi-2 beta; NF-kB p50; NF-kB p52; Ikaros NTS; Aiolos CTS; C/EBP beta; Ets1; Aof2 (LSD1); Macro H2A1.2; EED; Smyd2; Smyd5; TFIID; Elf-1; TAF150Monoclonals: .....
[更多]
Extended half-life/higher stabilitySmall molecular weight allows for delivery of more active ingredient per dose Modification is not known to induce immune response or hypersensitivity in humansCan be efficiently synthesized in large quantities using well established protocols
[更多]
| |< <- | [6532] [6533] [6534] [6535] [6536] [6537] [6538] [6539] [6540] [6541] [6542] | -> >| |
